Countries Hong Kong

Illumina and PHASE Scientific Forge Strategic Partnership to Drive Genomic Innovation in Greater Bay Area

llumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a...

 November 11, 2024 | News

Ascletis' ASC47 Shows Promise in Phase I Trial with Once-Monthly Dosing and Superior Fat Reduction in Obesity Treatment

Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed...

 November 08, 2024 | News

Hong Kong's Akeso Biopharma Advances Immunotherapy in Biliary Tract Cancer with First Patient Enrolled in Phase III Study of Ivonescimab

 Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the HARMONi-GI-01/AK112-309 study, a randomized, c...

 November 01, 2024 | News

Hong Kong’s Akeso Biopharma Enrolls First Patient in Pioneering Phase III Trial for Advanced Head and Neck Cancer Therapy

Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized, controlled, multicenter Phase III clinical study (A...

 October 31, 2024 | News

Hong Kong Approves Eli Lilly’s Mounjaro® as First Dual-Receptor Agonist for Obesity and Type 2 Diabetes

Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparato...

 October 28, 2024 | News

Everest Medicines’ VELSIPITY® Approved for Ulcerative Colitis in Greater Bay Area Hospitals under "Hong Kong and Macau Medicine Connect" Policy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

 October 25, 2024 | News

Antengene’s XPOVIO® Gains Third Approval in South Korea for Multiple Myeloma Treatment

This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...

 October 18, 2024 | News

Tencent Invests US$30 Million in Hong Kong’s Insighta, Valuing the Early Cancer Detection Company at US$200 Million

 Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, announced that Tencent has made a strategic US$30 million&n...

 October 16, 2024 | News

Akeso Biopharma Secures $250 Million in Share Placement to Accelerate Global Clinical Trials

Expediting International Clinical Trials for Pivotal Products Key Participants Include International Long-Term and Healthcare Funds Akeso Biopharma annou...

 October 14, 2024 | News

Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies

First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...

 October 03, 2024 | News

GenEditBio Secures Strategic Investment from Gobi Partners GBA to Advance Precision Genome Editing

GenEditBio Limited ("GenEditBio"), a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on pre...

 October 01, 2024 | News

Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals

The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...

 September 30, 2024 | News

MASSPHOTON and Sino Innovation Lab Launch World’s First Medical-Grade UVC LED Air Sterilizer

The experience of the COVID-19 pandemic has heightened global awareness of air quality and indoor environmental safety like never before. MASSPHOTON a...

 September 12, 2024 | News

HKBU’s Centre for Chinese Herbal Medicine Drug Development Receives Approval for Clinical Trial of Novel Ulcerative Colitis Drug

Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in dev...

 September 05, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close